Objective: To analyze whether the use of an intermittent (IAD) versus continuous (CAD) androgen deprivation therapy for the treatment of biochemical progression after primary treatments (radical prostatectomy and radiation therapy) in hormone sensitive non-metastatic prostate cancer can influence the development of non-metastatic castration resistant prostate cancer (CRPC-M0) .

INTERMITTENT VERSUS CONTINUOUS ANDROGEN DEPRIVATION THERAPY FOR BIOCHEMICAL PROGRESSION AFTER PRIMARY THERAPY IN HORMONE-SENSITIVE NON-METASTATIC PROSTATE CANCER: COMPARATIVE ANALYSIS IN TERMS OF CRPC-M0 PROGRESSION / Salciccia, Stefano; Frisenda, Marco; Tufano, Antonio; Pierro, Giovanni Di; Bevilacqua, Giulio; Rosati, Davide; Gobbi, Luca; Basile, Greta; Moriconi, Martina; Mariotti, Gianna; Forte, Flavio; Carbone, Antonio; Pastore, Antonio; Cattarino, Susanna; Sciarra, Alessandro; Gentilucci, Alessandro. - In: CLINICAL GENITOURINARY CANCER. - ISSN 1558-7673. - (2023). [10.1016/j.clgc.2023.08.008]

INTERMITTENT VERSUS CONTINUOUS ANDROGEN DEPRIVATION THERAPY FOR BIOCHEMICAL PROGRESSION AFTER PRIMARY THERAPY IN HORMONE-SENSITIVE NON-METASTATIC PROSTATE CANCER: COMPARATIVE ANALYSIS IN TERMS OF CRPC-M0 PROGRESSION

Salciccia, Stefano;Frisenda, Marco;Tufano, Antonio;Pierro, Giovanni Di;Bevilacqua, Giulio;Gobbi, Luca;Basile, Greta;Moriconi, Martina;Forte, Flavio;Pastore, Antonio;Cattarino, Susanna;Sciarra, Alessandro;Gentilucci, Alessandro
2023

Abstract

Objective: To analyze whether the use of an intermittent (IAD) versus continuous (CAD) androgen deprivation therapy for the treatment of biochemical progression after primary treatments (radical prostatectomy and radiation therapy) in hormone sensitive non-metastatic prostate cancer can influence the development of non-metastatic castration resistant prostate cancer (CRPC-M0) .
2023
prostate cancer, intermittent androgen ablation
01 Pubblicazione su rivista::01a Articolo in rivista
INTERMITTENT VERSUS CONTINUOUS ANDROGEN DEPRIVATION THERAPY FOR BIOCHEMICAL PROGRESSION AFTER PRIMARY THERAPY IN HORMONE-SENSITIVE NON-METASTATIC PROSTATE CANCER: COMPARATIVE ANALYSIS IN TERMS OF CRPC-M0 PROGRESSION / Salciccia, Stefano; Frisenda, Marco; Tufano, Antonio; Pierro, Giovanni Di; Bevilacqua, Giulio; Rosati, Davide; Gobbi, Luca; Basile, Greta; Moriconi, Martina; Mariotti, Gianna; Forte, Flavio; Carbone, Antonio; Pastore, Antonio; Cattarino, Susanna; Sciarra, Alessandro; Gentilucci, Alessandro. - In: CLINICAL GENITOURINARY CANCER. - ISSN 1558-7673. - (2023). [10.1016/j.clgc.2023.08.008]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1688448
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact